Rabies is typically characterized as a severe disease that is caused by the rabies virus. The humans are most likely to be infected through animal bites such as dogs, cats, bats, and other mammals. The central nervous system is affected by the rabies virus which causes severe impact to the brain and may ultimately cause death in serious cases. The major symptoms include anxiety, hallucination, insomnia, hydrophobia, paralysis hyper salivation, and others. Henceforth, early prevention from the rabies is vital with the help of vaccines.
Increasing global incidences of mortality because of rabies, the increasing issue of stray dogs in countries with low economic development are projected to drive the market over the predicted years. According to WHO, rabies cause fatalities approximately 10,000 people every year worldwide and almost 99% cases are because of dog bites. According to World Health Organization, rabies caused 59,000 deaths annually in 150 countries with 95% cases in rural districts in 2017.
Data Bridge Market Research analyses a growth rate in the human rabies vaccines market in the forecast period 2023-2030. The expected CAGR of the human rabies vaccines market tends to be around 4.7% in the mentioned forecast period. The market was valued at USD 963.53 million in 2022 and would grow to USD 1391.36 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific has been witnessing positive growth for the human rabies vaccines market throughout the forecasted period due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure.
Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-human-rabies-vaccines-market
North America dominates the market due to major product launches, high concentration of market players and manufacturers' presence, numerous acquisitions and partnerships among major players, and government initiatives toward rabies vaccination.
Key players operating in the human rabies vaccines market include:
Serum Institute of India Pvt. Ltd (India)
Novartis AG (Switzerland)
Cadila Pharmaceuticals (India)
Merck & Co., Inc. (U.S.)
Sanofi (France)
ADS Diagnostic Ltd (India)
GSK plc (U.K.)
Berna Biotech Pharma GmbH (Switzerland)
AstraZeneca (U.K.)
Related Reports:
Rabies Diagnostics Market https://www.databridgemarketresearch.com/reports/global-rabies-diagnostics-market
Rabies Prophylaxis Market https://www.databridgemarketresearch.com/reports/global-rabies-prophylaxis-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new report on Global Human Rabies Immunoglobulin (IM) Market is confident in meeting their needs and expectations.
The 2018 market research report on Global Human Rabies Immunoglobulin (IM) Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge.
The report will shed light on many critical points and trends of the industry which are useful for our esteemed clients.The report covers a vast expanse of information including an overview, comprehensive analysis, definitions and classifications, applications, and expert opinions, among others.
With the extent of information filled in the report, the presentation and style of the Global Human Rabies Immunoglobulin (IM) Market report is a noteworthy.Download a PDF Sample of this Report @ http://orbisresearch.com/contacts/request-sample/2206678#utm_source=shreyasThe Global Human Rabies Immunoglobulin (IM) Industry report provides key information about the industry, including invaluable facts and figures, expert opinions, and the latest developments across the globe.
Accurate forecasts and expert opinion from credible sources, and the recent R development in the industry is also a mainstay of the Human Rabies Immunoglobulin (IM) Market report.Access the complete report with TOC & List of Tables @ http://www.orbisresearch.com/reports/index/2018-market-research-report-on-global-human-rabies-immunoglobulin-im-industry#utm_source=shreyasThe report also focuses on the significance of industry chain analysis and all variables, both upstream and downstream.
Other significant information covering consumption, key regions and distributors, and raw material suppliers are also a covered in this report.Finally, the Human Rabies Immunoglobulin (IM) Market report ends with a detailed SWOT analysis of the market, investment feasibility and returns, and development trends and forecasts.
A recent report published by TheBusinessResearchCompany on Vaccines Market provides in-depth analysis of segments and sub-segments in the global as well as regional.The Vaccines Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global vaccines market.
The report covers the vaccines market’s segments- anti-infective vaccines, autoimmunity, conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, intramuscular (IM), subcutaneous (SC), oral, monovalent, multivalent, institutional sale, hospital pharmacies, retail pharmacies, and others.Vaccines Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years.
Jul 19, 2019 (AB Digital via COMTEX) -- Global Animal Vaccines Market is likely to expand at a CAGR of 5.65% during the forecast period (2018-2023).
The surging incidences of livestock diseases are likely to favour the market growth.
For instance, Boehringer Ingelheim launched two swine vaccines in 2015 in the market against Porcine Reproductive and Respiratory Syndrome.
Factors like rising prevalence of livestock diseases, growing adoption of companion animals, technological advancements in animal vaccines, and surging initiatives by the government are contributing to the growth of the market.
Animals serve as an important food source, milk, meat, protein, and other commercial products like wool and leather.
Some of the most commonly used veterinary vaccines comprises foot & mouth diseases vaccines, rabies vaccines, and equine influenza virus vaccines, which help to prevent the transmission of infectious agents.
